8
88
N. Alouane et al.
PAPER
–
1
When needed, the crude product was purified by flash chromatog-
raphy (FC) on silica gel.
IR (neat): 3244, 1710 cm .
1
H NMR (400 MHz, CDCl ): d = 0.79 (d, J = 6.6 Hz, 3 H, CH ), 4.19
m, 1 H, H-4), 5.68 (d, J = 8.1 Hz, 1 H, H-5), 7.04 (s, 1 H, NH),
.26–7.39 (m, 5 H, Ph).
3
3
(
7
Method B
To a suspension of diphosgene (0.20 mL, 1.7 mmol), Et N (2 mL)
3
1
3
C NMR (100 MHz, CDCl ): d = 17.5, 52.5, 81.1, 125.8, 128.2,
and activated charcoal (10 mg) in anhyd THF (10 mL), was added
aminoalcohol or diol or diamine (2 mmol) in THF (10 mL). The re-
action mixture was stirred at 50 °C until no starting material could
be detected by NMR. Workup procedure as for method A was fol-
lowed.
3
1
28.5, 135.1, 160.1.
Anal. Calcd for C H NO : C, 67.78; H, 6.26; N, 7.90; O, 18.06.
Found: C, 67.78; H, 6.26; N, 7.65.
1
0
11
2
(
4S,5S)-3,4-Dimethyl-5-oxazolidin-2-one (12)
This compound was prepared according method A, using (1S,2S)-
+)-pseudoephedrine (330 mg, 2 mmol). Oxazolidin-2-one 12 (328
mg, 86%) was obtained as a pale yellow solid without further puri-
(
4R)-4,5,5-Triphenyloxazolidin-2-one (1)
This compound was prepared according to method A, using (R)-2-
amino-1,2,2-triphenylethanol (25.9 g, 89 mmol). Oxazolidin-2-one
(
1
(25.0 g, 89%) was obtained as a white solid without further puri-
20
8
25
fication; mp 47 °C; [a] +37 (c = 1.00, CHCl ) {Lit. [a] +36.7
(c = 0.98, CHCl )}.
3
D
3
D
2
0
1b
25
fication; mp 245 °C; [a] +198 (c = 1.00, CHCl ) {Lit. [a]D
+
D
3
218 (c = 1.00, CHCl )}.
3
IR (neat): 3479, 1737 cm–1.
1
–
1
IR (neat): 274, 1755, 1727 cm .
H NMR (400 MHz, CDCl ): d = 1.19 (d, J = 6.3 Hz, 3 H, CH ), 2.70
3
3
1
H NMR (400 MHz, CDCl ): d = 5.54 (s, 1 H, CH), 5.64 (s, 1 H,
3
(s, 1 H, H-4), 3.39 (m, 1 H, H-5), 4.74 (d, J = 6.3 Hz, 3 H, NCH ),
3
NH), 7.08–7.71 (m, 15 H, Ph).
7
13
.19–7.33 (m, 5 H, Ph).
1
3
C NMR (100 MHz, CDCl ): d = 65.8, 90.7, 126.2, 126.5, 127.3,
3
C NMR (100 MHz, CDCl ): d = 17.1, 28.6, 61.1, 82.3, 125.9,
3
28.8, 128.9, 137.6, 157.7.
1
27.5, 127.8, 128.3, 128.4, 128.5, 128.7, 137.1, 138.8, 142.8, 158.2.
1
Anal. Calcd for C H NO : C, 79.98; H, 5.43; N, 4.44; O, 10.15.
Found: C, 79.95; H, 5.43; N, 4.42.
2
1
17
2
Anal. Calcd for C H NO : C, 69.09; H, 6.86; N, 7.32; O, 16.73.
Found: C, 67.69; H, 6.86; N, 6.95.
1
1
13
2
(
4S)-4-Phenyloxazolidin-2-one (9)
This compound was prepared according to method A, using (S)-(+)-
-phenylglycinol (274 mg, 2 mmol). Purification by FC (pentane–
Et O, 50:50) gave oxazolidin-2-one 9 (313 mg, 96%) as a white sol-
(
5S)-3-tert-Butyl-5-oxazolidin-2-one (13)
This compound was prepared according to method B, using (S)-2-
tert-butylamino)-1-phenylethanol (386 mg, 2 mmol). Purification
by FC (pentane–Et O, 50:50) gave oxazolidin-2-one 13 (400 mg,
2
(
2
2
20
6
25
id; mp 114 °C; [a] +55 (c = 1.00, CHCl ) {Lit. [a] +59 (c =
1
20
9
25
D
3
D
91%) as a pale yellow oil; [a] +59 (c = 1.20, CHCl ) {Lit. [a]
+49 (c = 1.00, CHCl )}.
D
3
D
.00, CHCl )}.
3
3
–
1
IR (neat): 3229, 1701 cm .
IR (neat): 2974, 1736 cm–1.
1
1
H NMR (400 MHz, CDCl ): d = 4.14 (dd, J = 6.8, 8.6 Hz, 1 H, H-
3
H NMR (400 MHz, CDCl ): d = 1.39 [s, 9 H, (CH ) ], 3.44 (dd,
3
3 3
5
), 4.71 (t, J = 8.6 Hz, 1 H, H-4), 4.95 (t, J = 8.6 Hz, 1 H, H-5), 6.78
J = 7.8, 8.6 Hz, 1 H, H-4), 3.96 (t, J = 8.6 Hz, 1 H, H-4), 5.35 (t,
J = 7.8 Hz, 1 H, H-5), 7.28–7.55 (m, 5 H, Ph).
(s, 1 H, NH), 7.28–7.41 (m, 5 H).
1
3
C NMR (100 MHz, CDCl ): d = 56.4, 72.5, 126.0, 128.7, 129.1,
13
3
C NMR (100 MHz, CDCl ): d = 27.4, 51.1, 53.5, 73.5, 125.5,
3
28.7, 128.8, 138.9, 156.8.
1
39.7, 160.3.
1
Anal. Calcd for C H NO : C, 66.25; H, 5.56; N, 8.58; O, 19.61.
Found: C, 66.38; H, 5.65; N, 8.52.
9
9
2
Anal. Calcd for C H NO : C, 71.21; H, 7.81; N, 6.39; O, 14.59.
Found: C, 69.29; H, 7.75; N, 6.55.
1
3
17
2
(
4S)-4-Isopropyloxazolidin-2-one (10)
(
4S)-4-Phenyl[1,3]dioxolan-2-one (21)
This compound was prepared according to method B, using (S)-(+)-
2
This compound was prepared according to method A, using (S)-1-
phenylethane-1,2-diol (276 mg, 2 mmol). Dioxolan-2-one 21 (306
mg, 93%) was obtained as a white solid without further purification;
mp 64 °C; [a]D –44 (c = 1.00, CHCl ) {Lit. [a]D –31 (c = 1.00,
CHCl )}.
-amino-3-methyl-1-butanol (0.22 mL, 2 mmol). Oxazolidin-2-one
1
0 (250 mg, 97%) was obtained as a pale yellow solid without fur-
2
0
6
25
ther purification; mp 59 °C; [a] –18 (c = 1.00, EtOH) {Lit. [a]
–
20
10
20
D
D
3
17 (c = 1.02, EtOH)}.
3
–
1
IR (neat): 3263, 1720 cm .
IR (neat): 3354, 2926, 1773 cm–1.
1
H NMR (400 MHz, CDCl ): d = 0.87 (d, J = 6.6 Hz, 3 H, CH ), 0.93
1
3
3
H NMR (400 MHz, CDCl ): d = 4.34 (t, J = 8.3 Hz, 1 H, H-5), 4.81
3
(
d, J = 6.6 Hz, 3 H, CH ), 1.63 (m, 1 H, H-4), 3.59 (q, J = 6.6, 8.3
3
(t, J = 8.3 Hz, 1 H, H-5), 5.68 (t, J = 8.3 Hz, 1 H, H-4), 7.22–7.55
Hz, 1 H, CH), 4.06 (dd, J = 6.3, 8.6 Hz, 1 H, H-5), 4.41 (t, J = 8.6
Hz, 1 H, H-5), 7.22 (s, 1 H, NH).
(
1
m, 5 H, Ph).
3
C NMR (100 MHz, CDCl ): d = 71.3, 78.1, 125.9, 129.3, 129.7,
3
1
3
C NMR (100 MHz, CDCl ): d = 17.63, 17.94, 32.69, 58.42, 68.62,
3
135.9, 155.0.
1
60.8.
Anal. Calcd for C H O : C, 65.85; H, 4.91; O, 29.24. Found: C,
65.82; H, 4.97.
9
8
3
Anal. Calcd for C H NO : C, 55.80; H, 8.58; N, 10.84; O, 24.78.
Found: C, 55.81; H, 8.64; N, 10.73.
6
11
2
(
4R,5R)-4,5-Diphenyl[1,3]dioxolan-2-one (22)
This compound was prepared according to method A, using
1R,2R)-1,2-diphenylethane-1,2-diol (363 mg, 1.7 mmol). Diox-
olan-2-one 22 (460 mg, 96%) was obtained as a pale yellow solid
(
4R,5S)-4-Methyl-5-phenyloxazolidin-2-one (11)
This compound was prepared according to method A, using
(
(
purification; mp 89 °C; [a] –166 (c = 1.00, CHCl ) {Lit. [a]
–
(
1R,2S)-(–)-norephedrin (300 mg, 2 mmol). Oxazolidin-2-one 11
329 mg, 93%) was obtained as a pale yellow solid without further
20
without further purification; mp 122 °C; [a]
CHCl ) {Lit. [a]D +66 (c = 1.05, CHCl )}.
IR (neat): 2945, 2857, 1813 cm–1.
+66 (c = 1.00,
D
2
0
7
20
11
20
D
3
D
3
3
170 (c = 1.20, CHCl )}.
3
Synthesis 2006, No. 5, 885–889 © Thieme Stuttgart · New York